Literature DB >> 25280540

Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting.

Kyung Dong Lee1, Seon-Hee Choi, Da Hye Kim, Hye-Young Lee, Ki-Choon Choi.   

Abstract

Folic acid-decorated self-organized nanoparticles were fabricated to target folate receptor of cancer cells. Doxorubicin (DOX) was conjugated with carboxyl group of dextran backbone using succinic anhydride (DexSU-DOX). DOX-loaded self-organized nanoparticles were prepared by complexation with folic acid-grafted chitosan (ChitoFA) and DexSU-DOX. Nanoparticles in the aqueous environment have spherical shapes with average size less than 100 nm and their sizes were increased by coated with ChitoPEG or ChitoFA. At cell culture study with KB cells, ChitoFA coated nanoparticles (FADex NP) revealed folate-receptor mediated endocytosis to cancer cells and cell viability was significantly changed by folate receptor targeting. Tumor xenograft model of KB cells also showed similar results, i.e. FAdex NP efficiently inhibited growth of tumor compared to the treatment group with blocking of folate receptor. These results indicated that DOX-loaded nanoparticles of FADex NP are promising vehicle for anticancer drug targeting.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25280540     DOI: 10.1007/s12272-014-0489-z

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  5 in total

Review 1.  Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.

Authors:  Behdokht Bahrami; Mousa Mohammadnia-Afrouzi; Peyman Bakhshaei; Yaghoub Yazdani; Ghasem Ghalamfarsa; Mehdi Yousefi; Sanam Sadreddini; Farhad Jadidi-Niaragh; Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2015-07-05

Review 2.  Folate-mediated chemotherapy and diagnostics: An updated review and outlook.

Authors:  Leyuan Xu; Qianming Bai; Xin Zhang; Hu Yang
Journal:  J Control Release       Date:  2017-02-22       Impact factor: 9.776

Review 3.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

4.  Synthesis of folate‑chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells.

Authors:  Lichun Cheng; Hui Ma; Mingkun Shao; Qing Fan; Huiyi Lv; Jinyong Peng; Tangna Hao; Daiwei Li; Chenyang Zhao; Xingyue Zong
Journal:  Mol Med Rep       Date:  2017-06-09       Impact factor: 2.952

Review 5.  Receptor-Mediated Drug Delivery Systems Targeting to Glioma.

Authors:  Shanshan Wang; Ying Meng; Chengyi Li; Min Qian; Rongqin Huang
Journal:  Nanomaterials (Basel)       Date:  2015-12-28       Impact factor: 5.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.